Wuhan General Group, Inc.: Financier Sheldon Inwentash Joins Wuhan General Group as Strategic Advisor CAPE TOWN, SA / ACCESSWIRE / January 27, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce today that the Company has entered into an advisory agreement with Sheldon Inwentash. Sheldon is well-known in the North American capital markets for his investment prowess and strategies, for revolutionizing the resource investment model and for creating very significant shareholder value and returns through early investments. He helps the companies in which he invests by providing counsel and guidance to the C-suite. Sheldon's investment approach has helped him build a remarkable reputation and track record. Sheldon will utilize his expertise and his industry resources to assist Wuhan's efforts to develop and grow.